GCC Equine Healthcare Market

GCC Equine Healthcare Market Research Report By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others), By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others), By Activity (Sports/Racing, Recreation, Others) and By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others) - Growth & Industry Forecast 2025 To 2035
ID: MRFR/HC/50663-HCR 200 Pages Nidhi Mandole, Rahul Gotadki Last Updated: September 11, 2026
GCC Equine Healthcare Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.04%
2024 Market Size$ 142.66 Million
2025 Market Size$ 149.85 Million
2035 Market Size$ 245 Million
Key Players
Merck Animal Health
Zoetis
Boehringer Ingelheim
Elanco Animal Health
Virbac
Dechra Pharmaceuticals
Trends
  • Technological Advancements in Veterinary Care
  • Increased Focus on Preventive Healthcare
  • Rising Demand for Specialized Services
Opportunities
  • Expansion of Veterinary Services
  • Growing Awareness of Equine Health
  • Regulatory Support for Equine Welfare
Request Free Sample

GCC Equine Healthcare Market Summary

As per Market Research Future analysis, the GCC equine healthcare market size was estimated at 142.66 USD Million in 2024. The GCC equine healthcare market is projected to grow from 149.85 USD Million in 2025 to 245.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 5.0% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The GCC equine healthcare market is experiencing robust growth driven by technological advancements and a shift towards preventive care.

  • Technological advancements in veterinary care are enhancing treatment options and improving outcomes for equine health.
  • There is an increased focus on preventive healthcare, which is likely to reduce long-term costs and improve equine welfare.
  • The demand for specialized services is rising, particularly in the largest segment of equine surgery and rehabilitation.
  • Key market drivers include growing awareness of equine health and rising participation in equestrian sports.

Market Size & Forecast

2024 Market Size 142.66 (USD Million)
2035 Market Size 245.0 (USD Million)
CAGR (2025 - 2035) 5.04%

Major Players

Merck Animal Health (US), Zoetis (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Virbac (FR), Dechra Pharmaceuticals (GB), Vetoquinol (FR), Heska Corporation (US)

GCC Equine Healthcare Market Drivers

Expansion of Veterinary Services

The equine healthcare market is witnessing an expansion of veterinary services across the GCC region. This growth is characterized by the establishment of specialized clinics and mobile veterinary units that cater specifically to equine needs. The increasing number of equine events and competitions in the region has further stimulated demand for comprehensive veterinary care. It is estimated that the market for equine veterinary services could reach $500 million by 2026, reflecting a robust growth trajectory. This expansion not only enhances service accessibility but also fosters a competitive environment that benefits horse owners.

Growing Awareness of Equine Health

The equine healthcare market is experiencing a notable increase in awareness regarding the health and well-being of horses among owners and trainers in the GCC. This heightened consciousness is likely driven by educational initiatives and the availability of information through various media. As a result, horse owners are more inclined to invest in regular veterinary check-ups and preventive care, which could lead to a projected growth rate of approximately 6% annually in the equine healthcare market. This trend indicates a shift towards prioritizing equine health, thereby enhancing the demand for veterinary services and products.

Regulatory Support for Equine Welfare

The equine healthcare market is positively influenced by regulatory frameworks that promote equine welfare in the GCC. Governments are increasingly implementing policies aimed at ensuring the health and safety of horses, which may include mandatory health checks and vaccination programs. Such regulations are likely to enhance the credibility of veterinary services and encourage horse owners to comply with health standards. This regulatory support could potentially lead to a 4% increase in the equine healthcare market as more owners seek to adhere to these guidelines, thereby driving demand for veterinary services.

Rising Participation in Equestrian Sports

The equine healthcare market is significantly impacted by the rising participation in equestrian sports across the GCC. As more individuals engage in activities such as show jumping, dressage, and endurance riding, the demand for specialized equine healthcare services is likely to increase. This trend is expected to drive investments in veterinary care, nutrition, and training, contributing to a projected market growth of approximately 7% over the next few years. The growing equestrian community is fostering a culture of responsible horse ownership, which in turn enhances the overall demand for equine healthcare services.

Technological Integration in Veterinary Practices

The equine healthcare market is benefiting from the integration of advanced technologies in veterinary practices within the GCC. Innovations such as telemedicine, digital health records, and diagnostic imaging are becoming more prevalent, allowing for improved efficiency and accuracy in equine healthcare. This technological shift is likely to enhance the quality of care provided to horses, making it more appealing for owners to seek veterinary assistance. As a result, the market may experience a growth rate of around 5% annually, reflecting the increasing reliance on technology in veterinary services.

Market Segment Insights

By Product: Vaccines (Largest) vs. Pharmaceuticals (Fastest-Growing)

In the GCC equine healthcare market, the segment values show a distinct distribution with Vaccines holding the largest share. Vaccines play a crucial role in equine health management and are recognized for their efficacy against numerous diseases. On the other hand, the Pharmaceuticals segment, though smaller, is rapidly gaining traction and reflects a significant shift towards advanced medication options for equine care. The growth trends in this segment are influenced by a rising demand for preventive healthcare solutions and increased awareness among equine owners. Additionally, advancements in pharmaceutical formulations and innovations in diagnostic tools are propelling the Pharmaceuticals segment to be the fastest-growing area. This scenario indicates a robust evolution in how equine healthcare services are approached within the region.

Vaccines (Dominant) vs. Pharmaceuticals (Emerging)

Vaccines are considered the dominant force in the GCC equine healthcare market due to their essential role in disease prevention among equines. They are characterized by extensive research and development, focusing on specific regional diseases affecting horses. Conversely, the Pharmaceuticals segment is emerging with innovative treatment options aimed at addressing various health conditions in horses, reflecting a shift towards more sophisticated medical interventions. This segment is characterized by continuous advancements in product formulations and growing investment in research, ensuring alignment with the evolving needs of equine healthcare. Both segments are vital, with Vaccines ensuring baseline health and Pharmaceuticals offering solutions for advanced medical needs.

By Indication: Musculoskeletal Disorders (Largest) vs. Parasite Control (Fastest-Growing)

The GCC equine healthcare market exhibits a diverse array of indications, with musculoskeletal disorders holding the largest share, driven by the prevalence of injuries among performance horses. Parasite control, while currently a smaller segment, is gaining momentum due to increasing awareness of equine health and hygiene. Thus, these segments illustrate varying degrees of market penetration, highlighting the demand for specific treatments based on horse care needs. Growth trends are substantially influenced by the rising equestrian activities and the increasing investment in horse health, specifically in musculoskeletal health and parasite control. The market is seeing a surge in innovative treatments aimed at musculoskeletal disorders, while enhanced parasite control protocols reflect a proactive approach in maintaining overall equine health. As horse welfare becomes a priority, these market segments are set for significant evolution and expansion.

Musculoskeletal Disorders (Dominant) vs. Parasite Control (Emerging)

Musculoskeletal disorders remain the dominant indication in the GCC equine healthcare market, reflective of both competitive equestrian sports and the physical demands placed on horses. These disorders often lead to performance downtimes, increasing the necessity for intervention. In contrast, parasite control is emerging as a vital area of focus, attributed to heightened awareness about health management and the adverse effects parasites can have on horses' well-being. This segment is characterized by an increasing adoption of preventive measures, which represents a shift towards proactive healthcare strategies. As both segments develop, they will contribute significantly to the overall landscape of equine healthcare, supporting the well-being of horses in the region.

By Activity: Sports/Racing (Largest) vs. Recreation (Fastest-Growing)

Within the activity segment of the GCC equine healthcare market, Sports/Racing holds the largest share, attributed to the region's rich equestrian heritage and competitive equine sports culture. This segment encompasses professional racing and sports-related healthcare services, reinforcing its position as a primary driver of revenue in the market. Meanwhile, the Recreation segment, fueled by a growing interest in horse riding among leisure enthusiasts, is rapidly emerging as a significant player, steadily gaining share due to a rising number of recreational events and activities. Growth trends reveal that the Sports/Racing segment is poised for sustained prominence, supported by ongoing investments in infrastructure and technology. In contrast, the Recreation segment is expected to witness the fastest growth as more individuals and families turn towards equestrian activities for recreation, wellness, and social engagement. This shift is driven by lifestyle changes, increased awareness of equine welfare, and enhanced accessibility to riding facilities, which are contributing to a robust expansion of interest in recreational horseback riding and related services.

Sports/Racing (Dominant) vs. Recreation (Emerging)

The Sports/Racing segment of the GCC equine healthcare market is characterized by its well-established infrastructure and a high concentration of elite equine athletes. This dominant segment benefits from substantial investments in training facilities, veterinary care, and health monitoring systems, ensuring that competitive horses receive top-tier care and support. On the other hand, the Recreation segment is emerging rapidly, capturing the interest of a diverse demographic that includes families and casual riders. As this segment grows, it is increasingly recognized for the potential to improve equine welfare and community engagement. Both segments, while distinct, contribute significantly to the overall development and maturation of the GCC equine healthcare market.

By Distribution Channel: Veterinary Hospitals & Clinics (Largest) vs. E-commerce (Fastest-Growing)

In the GCC equine healthcare market, the distribution of market share among the segments reveals a strong presence of Veterinary Hospitals & Clinics, which dominate the landscape and cater to a significant portion of equine healthcare needs. E-commerce is emerging rapidly, boosting accessibility and convenience for consumers seeking products and services related to equine health. The segment labeled 'Others' serves as a niche, catering to specialized needs but holding a smaller percentage of overall market share. Growth trends in the GCC equine healthcare market's distribution channel are primarily driven by increasing investments in veterinary services and a surge in online shopping preferences. The convenience afforded by e-commerce platforms resonates particularly well with younger demographics, leading to a vibrant and competitive marketplace. As awareness around equine health continues to rise, both traditional and digital channels are expected to experience substantial growth, highlighting the shift in consumer behavior toward more accessible healthcare solutions for their equine companions.

Veterinary Hospitals & Clinics (Dominant) vs. E-commerce (Emerging)

Veterinary Hospitals & Clinics are the dominant force in the GCC equine healthcare market, providing essential services such as routine check-ups, emergency care, and specialized treatment. These facilities often benefit from established reputations and relationships with equine owners, further solidifying their market position. The growing concerns regarding equine health fuels demand for these facilities, emphasizing the need for expert medical attention. On the other hand, E-commerce has emerged as a vital channel driven by technological advancements and changing consumer preferences. It offers a wide range of products, including medicines and supplements, with the added benefit of home delivery. This segment is gaining traction, especially among tech-savvy users who appreciate the ease of online transactions.

Equine Healthcare Market Distribution Channel Insights

Equine Healthcare Market Distribution Channel Insights

The distribution channel segment within the GCC Equine Healthcare Market plays a critical role in delivering essential products and services to horse owners and caretakers. Veterinary hospitals and clinics are pivotal as they provide specialized care and treatment, making them a primary choice for horse owners seeking professional assistance.

E-commerce has emerged as a significant channel, driven by the increasing adoption of online shopping and the demand for convenience, allowing customers to easily acquire equine health products without geographical restrictions.Other distribution methods, which may include feed stores and agricultural suppliers, also contribute to the market by providing accessible resources for equine health management. 

The diversification of distribution channels enhances product availability, ultimately supporting animal welfare in the GCC region. With a growing number of equestrian activities in countries within the GCC, the importance of these distribution channels is likely to expand, leading to opportunities for innovation and improved service delivery in the Equine Healthcare Market.

Get more detailed insights about GCC Equine Healthcare Market
Request Free Sample

Key Players and Competitive Insights

The equine healthcare market is currently characterized by a dynamic competitive landscape, driven by increasing demand for advanced veterinary services and products. Key players such as Merck Animal Health (US), Zoetis (US), and Boehringer Ingelheim (DE) are strategically positioned to leverage innovation and technological advancements. Merck Animal Health (US) focuses on developing cutting-edge vaccines and therapeutics, while Zoetis (US) emphasizes digital health solutions and data analytics to enhance veterinary care. Boehringer Ingelheim (DE) is actively pursuing partnerships to expand its product portfolio, particularly in biologics, which collectively shapes a competitive environment that is increasingly reliant on innovation and strategic collaborations.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness to market demands. The market appears moderately fragmented, with several players vying for market share, yet the influence of major companies is substantial. This competitive structure allows for a diverse range of products and services, catering to the varied needs of equine healthcare.

In October Merck Animal Health (US) announced the launch of a new equine vaccine aimed at combating a prevalent viral disease affecting horses. This strategic move not only reinforces Merck's commitment to innovation but also positions the company to capture a larger market share in the equine segment. The introduction of this vaccine is expected to enhance the overall health and performance of equine athletes, thereby appealing to a broad customer base.

In September Zoetis (US) unveiled a digital platform designed to streamline veterinary practices and improve client engagement. This initiative reflects Zoetis's focus on integrating technology into veterinary care, potentially transforming how equine healthcare is delivered. By enhancing operational efficiencies and client interactions, Zoetis aims to solidify its market leadership and drive growth in the digital health space.

In August Boehringer Ingelheim (DE) entered into a strategic partnership with a biotechnology firm to co-develop innovative therapies for equine respiratory diseases. This collaboration underscores the importance of partnerships in advancing research and development efforts. By pooling resources and expertise, Boehringer Ingelheim is likely to accelerate the introduction of novel treatments, thereby enhancing its competitive edge in the market.

As of November current trends in the equine healthcare market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in veterinary practices. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to leverage shared resources and expertise. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technology, and supply chain reliability, as companies strive to meet the growing expectations of equine owners and veterinarians.

Key Companies in the GCC Equine Healthcare Market include

Recent Industry Developments

The GCC Equine Healthcare Market has seen significant developments recently. In terms of current affairs, companies like Merck Animal Health and Zoetis are expanding their veterinary product portfolios to include innovative treatments and diagnostic solutions, responding to the growing demands for equine health management in the region. Growth in market valuation is evident, driven by increased awareness of animal health, equestrian activities, and rising disposable incomes among GCC residents. 

Notably, in September 2023, Vetoquinol announced an expansion of its distribution network in the GCC, enhancing its market presence. Merger and acquisition activity has also been notable, with Heska Corporation acquiring a veterinary diagnostics company in August 2023, which is expected to strengthen its offerings in the equine sector. Additionally, in May 2022, Boehringer Ingelheim acquired a company specializing in equine vaccines, enhancing its research capabilities. Furthermore, with GCC governments investing in animal health infrastructure and the equestrian industry, the market is poised for robust growth, indicating a thriving environment for veterinary companies such as Patterson Veterinary and Virbac.

These trends reflect an expanding commitment to equine health in the region as it becomes a more integrated part of the animal healthcare landscape.

Future Outlook

GCC Equine Healthcare Market Future Outlook

The Equine Healthcare Market is projected to grow at a 5.04% CAGR from 2025 to 2035, driven by advancements in veterinary technology and increasing equine population.

New opportunities lie in:

  • Development of telemedicine platforms for remote consultations
  • Expansion of specialized equine nutrition products
  • Implementation of integrated health management software for equine practices

By 2035, the equine healthcare market is expected to achieve robust growth and enhanced service offerings.

Market Segmentation

GCC Equine Healthcare Market Product Outlook

  • Vaccines
  • Pharmaceuticals
  • Medicinal Feed Additives
  • Diagnostics
  • Software & Services
  • Others

GCC Equine Healthcare Market Activity Outlook

  • Sports/Racing
  • Recreation
  • Others

GCC Equine Healthcare Market Indication Outlook

  • Musculoskeletal Disorders
  • Parasite Control
  • Internal Medicine
  • Equine Herpes Virus
  • Equine Encephalomyelitis
  • Equine Influenza
  • West Nile Virus
  • Tetanus
  • Others

GCC Equine Healthcare Market Distribution Channel Outlook

  • Veterinary Hospitals & Clinics
  • E-commerce
  • Others

Report Scope

MARKET SIZE 2024 142.66(USD Million)
MARKET SIZE 2025 149.85(USD Million)
MARKET SIZE 2035 245.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.04% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Merck Animal Health (US), Zoetis (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Virbac (FR), Dechra Pharmaceuticals (GB), Vetoquinol (FR), Heska Corporation (US)
Segments Covered Product, Indication, Activity, Distribution Channel
Key Market Opportunities Integration of telemedicine and digital health solutions in the equine healthcare market.
Key Market Dynamics Rising demand for advanced veterinary services drives innovation in equine healthcare solutions across the GCC region.
Countries Covered GCC

Frequently Asked Questions

What is the current valuation of the GCC equine healthcare market as of 2024?

The market valuation was $142.66 Million in 2024.

What is the projected market valuation for the GCC equine healthcare market in 2035?

The projected valuation for 2035 is $245.0 Million.

What is the expected CAGR for the GCC equine healthcare market during the forecast period 2025 - 2035?

The expected CAGR during this period is 5.04%.

Which companies are the key players in the GCC equine healthcare market?

Key players include Merck Animal Health, Zoetis, Boehringer Ingelheim, Elanco Animal Health, and others.

What are the main product segments in the GCC equine healthcare market?

Main product segments include Vaccines, Pharmaceuticals, Diagnostics, and others, with Pharmaceuticals valued at $50.0 - $85.0 Million.

What is the market size for musculoskeletal disorders in the GCC equine healthcare market?

The market size for musculoskeletal disorders ranges from $30.0 to $52.0 Million.

How does the distribution channel of veterinary hospitals and clinics perform in the market?

Veterinary hospitals and clinics have a market size of $85.0 - $145.0 Million.

What is the market size for recreational activities in the GCC equine healthcare market?

The market size for recreational activities is projected between $50.0 and $90.0 Million.

What is the valuation range for diagnostics in the GCC equine healthcare market?

Diagnostics are valued between $30.0 and $50.0 Million.

What are the expected trends in the GCC equine healthcare market by 2035?

By 2035, the market is likely to expand significantly, driven by increasing investments and advancements in equine healthcare.

Author
Author Author Profile Nidhi Mandole LinkedIn Senior Research Analyst
She is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Nidhi is comfortably versed in data centric research backed by healthcare educational background. She leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. Her key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, she showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Co-Author Co-Author Profile Rahul Gotadki LinkedIn Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.